...
首页> 外文期刊>AAPS PharmSciTech >The Influence of Sodium Carboxymethylcellulose on Drug Release from Polyethylene Oxide Extended Release Matrices
【24h】

The Influence of Sodium Carboxymethylcellulose on Drug Release from Polyethylene Oxide Extended Release Matrices

机译:羧甲基纤维素钠对聚环氧乙烷缓释基质中药物释放的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Anionic polymer sodium carboxymethylcellulose (CELLOGEN® HP-HS and/or HP-12HS) was investigated for its ability to influence the release of three model drugs propranolol hydrochloride, theophylline and ibuprofen from polyethylene oxide (POLYOX™ WSR 1105 and/or Coagulant) hydrophilic matrices. For anionic ibuprofen and non-ionic theophylline, no unusual/unexpected release profiles were obtained from tablets containing a mixture of two polymers. However, for cationic propranolol HCl, a combination of polyethylene oxide (PEO) with sodium carboxymethylcellulose (NaCMC) produced a significantly slower drug release compared to the matrices with single polymers. The potential use of this synergistic interaction can be a design of new extended release pharmaceutical dosage forms with a more prolonged release (beyond 12 h) using lower polymer amount, which could be particularly beneficial for freely water-soluble drugs, preferably for once daily oral administration. In order to explain changes in the obtained drug release profiles, Fourier transform infrared absorption spectroscopy was performed. A possible explanation for the more prolonged propranolol HCl release from matrices based on both PEO and NaCMC may be due to a chemical bond (i.e. ionic/electrostatic intermolecular interaction) between amine group of the cationic drug and carboxyl group of the anionic polymer, leading to a formation of a new type/form of the active (i.e. salt) with sustained release pattern.
机译:研究了阴离子聚合物羧甲基纤维素钠(CELLOGEN®HP-HS和/或HP-12HS)具有影响三种模型药物盐酸普萘洛尔,茶碱和布洛芬从聚环氧乙烷(POLYOX™WSR 1105和/或凝血剂)中释放的能力。矩阵。对于阴离子布洛芬和非离子茶碱,从含有两种聚合物混合物的片剂中未获得异常/意外释放曲线。但是,对于阳离子普萘洛尔HCl,与具有单一聚合物的基质相比,聚环氧乙烷(PEO)与羧甲基纤维素钠(NaCMC)的结合产生的药物释放明显较慢。这种协同作用的潜在用途可以是设计新的缓释药物剂型,使用较低的聚合物量,具有更长的释放时间(超过12小时),这对于自由水溶性药物(特别是每天一次口服)特别有利管理。为了解释所获得的药物释放曲线的变化,进行了傅里叶变换红外吸收光谱。基于PEO和NaCMC的盐酸普萘洛尔释放时间更长的可能解释可能是由于阳离子药物的胺基与阴离子聚合物的羧基之间的化学键(即离子/静电分子间相互作用)导致具有持续释放模式的新型活性物质(即盐)的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号